Expanding indications and developmental landscape of HER2-targeted therapies in breast cancer: a pharmacotherapeutic perspective

Hikari Sano, Hideyuki Hayashi, Naomi Nakao, Hiroko Hosoi, Shunsuke Kondo

Open source

DOI: 10.1080/14656566.2025.2591813
Published: 2025-11-19
Container: Expert Opinion on Pharmacotherapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14656566.2025.2591813,
  title = {Expanding indications and developmental landscape of HER2-targeted therapies in breast cancer: a pharmacotherapeutic perspective},
  author = {Hikari Sano and Hideyuki Hayashi and Naomi Nakao and Hiroko Hosoi and Shunsuke Kondo},
  year = {2025},
  journal = {Expert Opinion on Pharmacotherapy},
  doi = {10.1080/14656566.2025.2591813},
  url = {https://doi.org/10.1080/14656566.2025.2591813}
}

RIS

TY  - JOUR
TI  - Expanding indications and developmental landscape of HER2-targeted therapies in breast cancer: a pharmacotherapeutic perspective
AU  - Hikari Sano
AU  - Hideyuki Hayashi
AU  - Naomi Nakao
AU  - Hiroko Hosoi
AU  - Shunsuke Kondo
PY  - 2025
JO  - Expert Opinion on Pharmacotherapy
DO  - 10.1080/14656566.2025.2591813
UR  - https://doi.org/10.1080/14656566.2025.2591813
ER  -

APA

Sano, H., Hayashi, H., Nakao, N., Hosoi, H., & Kondo, S. (2025). Expanding indications and developmental landscape of HER2-targeted therapies in breast cancer: a pharmacotherapeutic perspective. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2025.2591813

Source records

crossref · retrieved 2026-11-11T00:15:22.953Z